OMAHA, NEBRASKA -- (Marketwire) -- 08/07/08 -- Qualia Clinical Services now offers full-scale Phase I-IV clinical trial support to companies interested in conducting clinical trials in Ukraine and Central Europe. Since operations began in Kiev, Ukraine earlier this year, Qualia has several studies underway, with many more expected in 2008.
This new division in Eastern Europe is ideal for providing clients immediate access to drug naive patients with medical conditions that can be very difficult to find in other areas of the world. These include Diabetes, Oncology, Hepatitis C, HIV+, Hepatic & Renal Failure, GI Disorders, and many more.
Qualia maintains a unique database of investigational sites in Ukraine and Central Europe, where they have developed extensive professional and personal relationships with highly qualified teams experienced in ICH-GCP compliant studies across various therapeutic areas. "We ensure the integrity of clinical trials by selecting investigators experienced in conducting industry-sponsored GCP compliant clinical trials," said Dr. Sergiy Pakharyna, Medical Director.
Clients can choose to outsource only a part of management of the clinical trial or can utilize Qualia's proven network of facilities and partnerships to effectively complete nearly every aspect of the clinical research process.
Qualia Clinical Services is a full service CRO with locations in the US, Canada and Europe. Qualia provides Early and Late Phase development, including Clinical Conduct, Patient Recruitment, Scientific Consultation, Protocol and CRF Design, and Data Management. Team Qualia has over 100 years of combined industry experience with a wealth of knowledge in a variety of therapeutic areas. More information about Qualia can be obtained through its website at www.qualiaclinical.com.
.gif)
